UPLIZNA 10 mg/mL
Inebilizumab · INJECTION · Horizon Therapeutics USA, Inc.
No Recall History
Plain English
UPLIZNA is a injection containing inebilizumab at 10 mg/mL, taken intravenous. Manufactured by Horizon Therapeutics USA, Inc..
Key Facts
- Brand Name
- UPLIZNA
- Generic Name
- Inebilizumab
- NDC Code (Product)
75987-150- Manufacturer
- Horizon Therapeutics USA, Inc.
- Strength
- 10 mg/mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761142
- Drug Class
- CD19-directed Cytolytic Antibody [EPC]
- Marketing Start
- 06/11/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is UPLIZNA used for?
UPLIZNA contains Inebilizumab. It is a injection taken intravenous. Consult your doctor for specific uses.
Is UPLIZNA a controlled substance?
UPLIZNA is not classified as a controlled substance by the DEA.
What is the generic name for UPLIZNA?
The generic name for UPLIZNA is Inebilizumab. There are no other listed brand versions of Inebilizumab.
What is the NDC code for UPLIZNA 10 mg/mL?
The NDC (National Drug Code) for UPLIZNA 10 mg/mL is 75987-150, listed by Horizon Therapeutics USA, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)